Published in Biosystems on January 01, 1995
Timescale analysis of rule-based biochemical reaction networks. Biotechnol Prog (2011) 0.84
Graphical approach to model reduction for nonlinear biochemical networks. PLoS One (2011) 0.81
A multiscale systems perspective on cancer, immunotherapy, and Interleukin-12. Mol Cancer (2010) 0.79
Short relaxation times but long transient times in both simple and complex reaction networks. J R Soc Interface (2016) 0.75
Time Hierarchies and Model Reduction in Canonical Non-linear Models. Front Genet (2016) 0.75
Issues in cDNA microarray analysis: quality filtering, channel normalization, models of variations and assessment of gene effects. Nucleic Acids Res (2001) 12.92
Improving lycopene production in Escherichia coli by engineering metabolic control. Nat Biotechnol (2000) 2.53
Gene expression profiling by DNA microarrays and metabolic fluxes in Escherichia coli. Biotechnol Prog (2000) 2.42
Estimation of nitric oxide production and reaction rates in tissue by use of a mathematical model. Am J Physiol (1998) 2.20
DNA microarray detection of metabolic responses to protein overproduction in Escherichia coli. Metab Eng (2000) 1.91
Effective diffusion distance of nitric oxide in the microcirculation. Am J Physiol (1998) 1.83
Metabolic engineering of Escherichia coli for 1-butanol and 1-propanol production via the keto-acid pathways. Metab Eng (2008) 1.77
Erythrocytes possess an intrinsic barrier to nitric oxide consumption. J Biol Chem (2000) 1.70
Arginase modulates nitric oxide production in activated macrophages. Am J Physiol (1998) 1.63
Macrophage arginase promotes tumor cell growth and suppresses nitric oxide-mediated tumor cytotoxicity. Cancer Res (2001) 1.62
Engineering of Escherichia coli central metabolism for aromatic metabolite production with near theoretical yield. Appl Environ Microbiol (1994) 1.57
Enhanced production of succinic acid by overexpression of phosphoenolpyruvate carboxylase in Escherichia coli. Appl Environ Microbiol (1996) 1.56
Stimulation of glucose catabolism in Escherichia coli by a potential futile cycle. J Bacteriol (1992) 1.47
Alteration of growth yield by overexpression of phosphoenolpyruvate carboxylase and phosphoenolpyruvate carboxykinase in Escherichia coli. Appl Environ Microbiol (1993) 1.46
Modulation of nitric oxide bioavailability by erythrocytes. Proc Natl Acad Sci U S A (2001) 1.45
Precursor balancing for metabolic engineering of lycopene production in Escherichia coli. Biotechnol Prog (2001) 1.45
Control of gluconeogenic growth by pps and pck in Escherichia coli. J Bacteriol (1993) 1.43
Isolation of a cDNA encoding a UV-damaged DNA binding factor defective in xeroderma pigmentosum group E cells. Mutat Res (1996) 1.42
Reduction of aerobic acetate production by Escherichia coli. Appl Environ Microbiol (1997) 1.41
Engineered synthetic pathway for isopropanol production in Escherichia coli. Appl Environ Microbiol (2007) 1.35
Children with mucopolysaccharidosis: perioperative care, morbidity, mortality, and new findings. J Pediatr Surg (1993) 1.30
Erythrocyte consumption of nitric oxide: competition experiment and model analysis. Nitric Oxide (2001) 1.27
Engineered isoprenoid pathway enhances astaxanthin production in Escherichia coli. Biotechnol Bioeng (1999) 1.26
Metabolic responses to substrate futile cycling in Escherichia coli. J Biol Chem (1994) 1.25
Pathway engineering for production of aromatics in Escherichia coli: Confirmation of stoichiometric analysis by independent modulation of AroG, TktA, and Pps activities. Biotechnol Bioeng (1995) 1.20
Determination of Flux Control Coefficients from transient metabolite concentrations. Biochem J (1992) 1.18
Neonatal circumcision. Pediatr Clin North Am (2001) 1.12
Spatial specificity of chromophore assisted laser inactivation of protein function. Biophys J (1992) 1.11
Directed evolution of metabolically engineered Escherichia coli for carotenoid production. Biotechnol Prog (2000) 1.08
Metabolic engineering of isoprenoids. Metab Eng (2001) 1.05
Metabolic control analysis using transient metabolite concentrations. Determination of metabolite concentration control coefficients. Biochem J (1992) 1.04
oxLDL specifically impairs endothelium-dependent, NO-mediated dilation of coronary arterioles. Am J Physiol Heart Circ Physiol (2000) 1.02
Inverse flux analysis for reduction of acetate excretion in Escherichia coli. Biotechnol Prog (1997) 1.01
Action of angiotensin on vascular adrenergic nerve endings: facilitation of norepinephrine release. Fed Proc (1972) 1.00
Retinoblastoma protein-interacting zinc-finger gene 1 (RIZ1) dysregulation in human malignant meningiomas. Oncogene (2012) 0.97
Metabolic engineering and control analysis for production of aromatics: Role of transaldolase. Biotechnol Bioeng (1997) 0.93
Downregulation of endothelial constitutive nitric oxide synthase expression by lipopolysaccharide. Biochem Biophys Res Commun (1996) 0.92
Alteration of product specificity of Rhodobacter sphaeroides phytoene desaturase by directed evolution. J Biol Chem (2001) 0.92
Red blood cell sorbitol lowering effects and tolerance of single doses of AL 1576 (HOE 843) in diabetic patients. J Clin Pharmacol (1988) 0.90
Effects of pharmacologic alterations of adrenergic mechanisms by cocaine, tropolone, aminophylline, and ketamine on epinephrine-induced arrhythmias during halothane-nitrous oxide anesthesia. Anesthesiology (1977) 0.90
Reversed phase high performance liquid chromatographic separations of nucleotides in the presence of solvophobic ions. Anal Chem (1977) 0.88
Cathepsins J and K: high molecular weight cysteine proteinases from human tissues. Biochem Biophys Res Commun (1984) 0.88
Incorporating qualitative knowledge in enzyme kinetic models using fuzzy logic. Biotechnol Bioeng (1999) 0.85
Effects of ultraviolet light irradiation in biotreatment of organophosphates. Appl Biochem Biotechnol (1996) 0.85
Microbial pathway engineering for industrial processes: evolution, combinatorial biosynthesis and rational design. Curr Opin Microbiol (2001) 0.85
Rapid detection of urinary tract infections using isotachophoresis and molecular beacons. Anal Chem (2011) 0.85
Lipopolysaccharide activates endothelial nitric oxide synthase through protein tyrosine kinase. Biochem Biophys Res Commun (1998) 0.84
Effectiveness of preoperative sedation with rectal midazolam, ketamine, or their combination in young children. Anesth Analg (1992) 0.83
Effect of phenoxybenzamine and combined administration of iproniazid and tropolone on catecholamine release elicited by renal sympathetic nerve stimulation. J Pharmacol Exp Ther (1971) 0.83
Transcriptional regulation and metabolism. Biochem Soc Trans (2005) 0.83
Heterologous protein expression affects the death kinetics of baculovirus-infected insect cell cultures: a quantitative study by use of n-target theory. Biotechnol Prog (1994) 0.82
Pelvi-ureteric junction obstruction treated with Acucise retrograde endopyelotomy. Br J Urol (1998) 0.81
High-performance liquid chromatography of pyruvic and alpha-ketoglutaric acids and its application to urine samples. Clin Chem (1977) 0.81
The efficacy of retinoic acid ointment for treatment of xerophthalmia and corneal epithelial wounds. Curr Eye Res (1985) 0.81
Experimental determination of flux control distribution in biochemical systems: in vitro model to analyze transient metabolite concentrations. Biotechnol Bioeng (1993) 0.80
Acetate-inducible protein overexpression from the glnAp2 promoter of Escherichia coli. Biotechnol Bioeng (2001) 0.79
Management of odontogenic orbital cellulitis. J Med Life (2011) 0.77
A synthetic iterative pathway for ketoacid elongation. Methods Enzymol (2011) 0.76
A mutant phosphoenolpyruvate carboxykinase in Escherichia coli conferring oxaloacetate decarboxylase activity. J Bacteriol (1995) 0.75
Improved stability of methanolic wright's stain with additive reagents. Stain Technol (1981) 0.75
Rflex vasodilatation in the cat and dog anesthetized with ketamine. Proc Soc Exp Biol Med (1973) 0.75
Dissimilarities between droperidol and phentolamine on vascular tone and dopamine and norepinephrine vasoconstriction. Res Commun Chem Pathol Pharmacol (1982) 0.75
Uptake of 14C-angiotensin by canine cutaneous blood vessels. Blood Vessels (1975) 0.75
Cathepsin J: a high molecular weight cysteine proteinase from human tissues. Prog Clin Biol Res (1985) 0.75
Effect of angiotensin on uptake of 3 H-norepinephrine in dog cutaneous arteries. Proc Soc Exp Biol Med (1972) 0.75
The design of intracellular oscillators that interact with metabolism. Cell Mol Life Sci (2006) 0.75
A hybrid approach to modeling metabolic systems using a genetic algorithm and simplex method. IEEE Trans Syst Man Cybern B Cybern (1998) 0.75
Response to sympathetic stimulation during angiotensin tachyphylaxis in dog's paw. Arch Int Pharmacodyn Ther (1972) 0.75
High pressure liquid chromatography of p-methoxyanilides of fatty acids. Anal Chem (1976) 0.75
Adrenergic responses in canine cutaneous vasculature during acute hemorrhagic hypotension. Am J Physiol (1975) 0.75
Improved stability of methanolic Wright's stain solution with dual additives. Stain Technol (1982) 0.75
Extraction and determination of chloroform in rat blood and tissues by gas chromatography-electron-capture detection: distribution of chloroform in the animal body. Clin Chem (1980) 0.75
Anesthetic management of infants receiving an adult kidney transplant. Anesth Analg (1991) 0.75
Colorimetric determination of a polymeric quaternary ammonium antimicrobial preservative in an ophthalmic solution. J Assoc Off Anal Chem (1988) 0.75
Kinetic characterization of baculovirus-induced cell death in insect cell cultures. Biotechnol Bioeng (1993) 0.75
Respiratory failure in newborns, infants and children. Indian J Pediatr (1981) 0.75